文献速递乳腺MR

HER2阳性/激素受体阴性乳腺癌术前乳腺MRI:倾向性评分匹配的手术结局

Preoperative breast MRI in HER2-positive/hormone receptor-negative breast cancer: surgical outcomes using propensity score matching.
PubMed 文献 · Eur Radiol · 2025-03-20

回顾性纳入2007至2014年965例HER2阳性/HR阴性浸润性导管癌患者,423例(44%)接受术前MRI。经逆概率加权和倾向性评分匹配调整17个协变量后,MRI组初始乳房切除术(OR 0.63/0.67)和总体乳房切除术(OR 0.60/0.68)的几率均低于未MRI组。无症状或多灶/多中心病变患者从MRI获益更多。

要点

  • HER2阳性/HR阴性乳腺癌术前MRI与较低的乳房切除术几率相关(OR 0.60–0.68)。
  • MRI组48例(11%)手术方式改变,其中31例(65%)改变是适当的。
  • 无症状患者或多灶/多中心病变患者从术前MRI获益更多。

核心结论

  • 接受术前MRI的HER2阳性/HR阴性乳腺癌患者行乳房切除术的可能性较低。

研究设计与样本

  • 回顾性研究,纳入2007至2014年965例HER2阳性/HR阴性浸润性导管癌患者,其中423例(44%)接受术前MRI、542例(56%)未接受,采用逆概率加权分析和倾向性评分匹配调整17个协变量。

诊断标准与关键数值

  • MRI组48例(11%)发生手术方式改变,其中31例(65%)改变是适当的。
  • MRI组初始乳房切除术几率较低:逆概率加权分析OR 0.63(95%CI 0.47, 0.84;p=0.002),倾向性评分匹配OR 0.67(95%CI 0.48, 0.92;p=0.01)。
  • MRI组总体乳房切除术几率较低:逆概率加权分析OR 0.60(95%CI 0.45, 0.80;p=0.001),倾向性评分匹配OR 0.68(95%CI 0.49, 0.93;p=0.02)。
  • 亚组分析中无症状患者从MRI获益更多(61% vs 36%,p=0.006),多灶或多中心病变患者从MRI获益更多(52% vs 31%,p=0.02)。

临床应用与阅片要点

  • HER2阳性/HR阴性乳腺癌患者术前MRI与较低的乳房切除术几率相关,且未增加阳性切缘或再手术率。
  • 术前MRI可能对无症状患者或多灶/多中心病变患者更有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To examine the association between preoperative magnetic resonance imaging (MRI) and surgical outcomes in human epidermal growth factor receptor 2 (HER2)-positive/hormone receptor (HR)-negative breast cancer through a propensity score (PS)-matched analysis.

MATERIALS AND METHODS: Patients with HER2-positive/HR-negative invasive ductal carcinoma between 2007 and 2014 were retrospectively assessed and compared according to whether they underwent preoperative MRI. Inverse probability weighting (IPW) analysis and PS matching were used to adjust 17 covariates to control between the MRI and no-MRI groups. Surgical outcomes were compared between two groups and clinicopathologic variables were evaluated to determine who benefited from MRI.

RESULTS: Among 965 women (mean age ± standard deviation, 52 years ± 10), 423 (44%) underwent preoperative MRI and 542 (56%) did not. In the MRI group, a change in surgical management occurred in 48 patients (11%), and the change was appropriate in 31 of those patients (65%). The MRI group had a lower odds of initial mastectomy (odds ratio [OR], 0.63; 95% confidence interval [CI]: 0.47, 0.84; p = 0.002 and OR, 0.67; 95% CI: 0.48, 0.92; p = 0.01 for IPW and PS matching, respectively) and overall mastectomy (OR, 0.60; 95% [CI]: 0.45, 0.80; p = 0.001 and OR, 0.68; 95% CI: 0.49, 0.93; p = 0.02 for IPW and PS matching, respectively). In the subgroup analysis, asymptomatic patients or those with multifocal or multicentric lesions benefited more from MRI (61% vs 36%, p = 0.006 and 52% vs 31%, p = 0.02, respectively).

CONCLUSION: Patients with HER2-positive/HR-negative breast cancer who received preoperative MRI had a lower likelihood of undergoing mastectomy.

KEY POINTS: Question The role of preoperative MRI in predicting surgical outcomes in patients with HER2-positive/HR-negative breast cancer remains uncertain. Findings Preoperative MRI in HER2-positive/HR-negative breast cancer reduces mastectomy rates without increasing the positive resection margin or reoperation rate. Clinical relevance Preoperative MRI is beneficial in reducing mastectomy rates in women with HER2-positive/HR-negative breast cancer.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Eom HJ, Choi WJ, Sun YJ, et al. Preoperative breast MRI in HER2-positive/hormone receptor-negative breast cancer: surgical outcomes using propensity score matching. Eur Radiol. 2025. PMID: 40108012. doi:10.1007/s00330-025-11494-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。